UMIN ID: UMIN000001744
Registered date:21/03/2009
A pilot study of interferon alpha suppository treatment for chronic hepatitis C
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Chronic hepatitis C |
| Date of first enrollment | 1998/10/01 |
| Target sample size | 28 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Lymphoblastoid interferon (1000IU) containing suppository Suppository matrix |
Outcome(s)
| Primary Outcome | Antiviral effect (decline of the viral load) |
|---|---|
| Secondary Outcome | (1)Improvement of liver function (2)Adverse effect |
Key inclusion & exclusion criteria
| Age minimum | 19years-old |
|---|---|
| Age maximum | 69years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Previous or present treatment with interferon, average daily intake of alcohol exceeding 50g of ethanol, choledocholithiasis, cirrhosis, autoimmune hepatitis, primary biliary cirrhosis, hepatitis B virus infection, human immunodeficiency virus infection, drug abuser, drug-related liver disease and pregnancy |
Related Information
| Primary Sponsor | Osaka Prefectural General Medical Center |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Osaka Prefectural General Medical Center |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Yoshimichi Haruna |
| Address | Japan |
| Telephone | |
| apple-123-grape@ab.auone-net.jp | |
| Affiliation | Osaka Prefectural General Medical Center Department of Gastroenterology and Hepatology |
| scientific contact | |
| Name | Yoshimichi Haruna |
| Address | 3-1-56 Bandaihigashi, Sumiyoshiku, Osaka 558-8558, Japan Japan |
| Telephone | 06-6692-1201 |
| Affiliation | Osaka Prefectural General Medical Center Department of Gastroenterology and Hepatology |